In addition, high expression of ITGAV significantly influenced the level of immune cell infiltration in lung adenocarcinoma and Triple-Negative breast cancer and was associated with poor prognosis in head and neck squamous cell carcinoma (HNSCC) and osteosarcoma (16–19). This evidence concerns the gene ITGAV and head and neck squamous cell carcinoma.